ACP5 and periodontitis: Administration of KP-A038 decreased the numbers of TRAP-positive osteoclasts as well as bone resorption in vivo (Figure 3), indicating that KP-A038 may have the potential to not only protect from the risk of inflammatory bone loss in periodontitis but also to contribute to bone regeneration in the oral cavity.